Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 8 December 2015, 22:30 HKT/SGT
Share:
    

Source: Lubrizol
Lubrizol LifeSciences Announces $15 Million Vesta Investment

CLEVELAND, Ohio, Dec 8, 2015 - (ACN Newswire) - The Lubrizol Corporation's LifeSciences business is investing $15 million to expand its global manufacturing facilities, positioning LifeSciences to better serve the growing market for medical device contract manufacturing. Since 2014, Lubrizol LifeSciences has solidified its presence in the life sciences market by introducing new products and making strategic acquisitions. This capital investment will expand multiple facilities and increase Lubrizol LifeSciences' in-house engineering capacity for both silicone and thermoplastic products.

"We have significantly enhanced our capabilities through the combination of strong polymer technology, application know-how and world-class component manufacturing," states Deb Langer, vice president and general manager, Lubrizol LifeSciences. "As healthcare companies look for total solution providers, we continue to invest in the right areas to provide valuable offerings to our customers."

Vesta, Inc., acquired by Lubrizol in August of 2014, is a leading contract manufacturer for the global medical device industry. With the addition of Vesta, Lubrizol LifeSciences now offers disposable and implantable silicone medical components and assemblies across a wide product portfolio, as well as precision thermoplastic extruded tubing. The recent acquisition of Particle Sciences, Inc., a leading contract drug development and manufacturing organization, has positioned Lubrizol LifeSciences as one of the most comprehensive drug delivery device solution providers, offering end-to-end solutions in the healthcare market.

"When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process," states Robert Miller, global business director, medical devices. "With a long history of polymer expertise and significant investment, Lubrizol LifeSciences is positioned to offer full-service development for next generation medical and pharmaceutical innovations."

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care and personal care products and pharmaceuticals, and specialty materials, including plastics technology and performance coatings in the form of specialty resins and additives. Our products for the oilfield market include technologies for exploration, production and transportation.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 9,000 employees worldwide. Revenues for 2014 were $7 billion. For more information, visit Lubrizol.com.

Media Contact
Ben Patti
+1-216-447-5827
www.lubrizol.com/LifeSciences
www.vestainc.com

###

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire


Dec 8, 2015 22:30 HKT/SGT
Topic: Press release summary

http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Lubrizol
Feb 20, 2018 20:20 HKT/SGT
Lubrizol Expands Global Capabilities and TPU Capacity
Feb 12, 2018 18:00 HKT/SGT
Lubrizol to Exhibit at PaintIndia 2018
Feb 7, 2018 08:30 HKT/SGT
Lubrizol LifeSciences to Showcase Full-Service Medical Device Solutions at MD&M West 2018
Jan 29, 2018 22:30 HKT/SGT
Lubrizol Exhibits at Northwest Materials Show
Jan 26, 2018 23:30 HKT/SGT
Lubrizol Highlights Unique Technologies at ISPO 2018
Jan 4, 2018 14:30 HKT/SGT
Lubrizol Launches New Breathable, Microbe-resistant Grades
Jan 3, 2018 20:30 HKT/SGT
Lubrizol Appoints Simko S.A. as New Distributor in Argentina
Jan 8, 2016 11:50 HKT/SGT
Lubrizol to Launch Estane(R) SMART TPU Series for Smart Wearable Devices Market
Jan 6, 2016 08:20 HKT/SGT
Lubrizol Participates In The TPE Thermoplastic Elastomers World Summit Conference
Nov 20, 2015 10:00 HKT/SGT
Lubrizol Invests in Stationary Natural Gas, Announces Two New Additive Solutions
More news >>
 News Alerts
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: